Advertisement
Screener

RESPONSE BIOMEDICAL CORP Revenue

RESPONSE BIOMEDICAL CORP Revenue

RESPONSE BIOMEDICAL CORP reported Revenue of CAD 1.58 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Income Statement

us-gaap:SalesRevenueNet · last filed 2016-11-14

  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was 1.58M CAD, a 55.10% decline year-over-year.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was 1.32M CAD, a 69.03% decline year-over-year.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 2.20M CAD, a 37.74% decline year-over-year.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2015-12-31 was 4.08M CAD, a 28.47% increase year-over-year.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2015 was 15.42M CAD, a 39.99% increase from fiscal 2014.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2014 was 11.01M CAD, a 4.48% decline from fiscal 2013.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2013 was 11.53M CAD, a 1.86% decline from fiscal 2012.
  • RESPONSE BIOMEDICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2012 was 11.75M CAD.
Period endRevenue, Net (Deprecated 2018-01-31) 3 monthRevenue, Net (Deprecated 2018-01-31) 6 monthRevenue, Net (Deprecated 2018-01-31) 9 monthRevenue, Net (Deprecated 2018-01-31) 12 month
2016-09-301.58M CAD
10-Q · filed 2016-11-14
2.90M CAD
derived: sum of 2 quarters · filed 2016-11-14
5.11M CAD
10-Q · filed 2016-11-14
9.19M CAD
derived: sum of 4 quarters · filed 2016-11-14
2016-06-301.32M CAD
10-Q · filed 2016-08-15
3.52M CAD
10-Q · filed 2016-08-15
7.61M CAD
derived: sum of 3 quarters · filed 2016-08-15
11.14M CAD
derived: sum of 4 quarters · filed 2016-11-14
2016-03-312.20M CAD
10-Q · filed 2016-05-16
6.29M CAD
derived: sum of 2 quarters · filed 2016-05-16
9.82M CAD
derived: sum of 3 quarters · filed 2016-11-14
14.08M CAD
derived: sum of 4 quarters · filed 2016-11-14
2015-12-314.08M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24
7.61M CAD
derived: sum of 2 quarters · filed 2016-11-14
11.88M CAD
derived: sum of 3 quarters · filed 2016-11-14
15.42M CAD
10-K · filed 2016-03-24
2015-09-303.53M CAD
10-Q · filed 2016-11-14
7.79M CAD
derived: sum of 2 quarters · filed 2016-11-14
11.33M CAD
10-Q · filed 2016-11-14
14.51M CAD
derived: sum of 4 quarters · filed 2016-11-14
2015-06-304.27M CAD
10-Q · filed 2016-08-15
7.81M CAD
10-Q · filed 2016-08-15
10.98M CAD
derived: sum of 3 quarters · filed 2016-08-15
13.18M CAD
derived: sum of 4 quarters · filed 2016-08-15
2015-03-313.54M CAD
10-Q · filed 2016-05-16
6.72M CAD
derived: sum of 2 quarters · filed 2016-05-16
8.92M CAD
derived: sum of 3 quarters · filed 2016-05-16
11.99M CAD
derived: sum of 4 quarters · filed 2016-05-16
2014-12-313.18M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24
5.38M CAD
derived: sum of 2 quarters · filed 2016-03-24
8.46M CAD
derived: sum of 3 quarters · filed 2016-03-24
11.01M CAD
10-K · filed 2016-03-24
2014-09-302.20M CAD
10-Q · filed 2015-11-13
5.28M CAD
derived: sum of 2 quarters · filed 2015-11-13
7.83M CAD
10-Q · filed 2015-11-13
2014-06-303.08M CAD
10-Q · filed 2015-08-14
5.64M CAD
10-Q · filed 2015-08-14
2014-03-312.56M CAD
10-Q · filed 2015-05-08
2013-12-3111.53M CAD
10-K · filed 2016-03-24
2012-12-3111.75M CAD
10-K · filed 2015-03-19